Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705
Guillame B E Stewart-Jones1, Kati di Gleria, Simon Kollnberger
1The Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, Oxford, UK.
Abstract:
We have solved the crystal structures of three HLA-B*2705-peptide complexes with the immunodominant viral peptides: EBV EBNA3C 258-266 (RRIYDLIEL), influenza (flu) nucleoprotein NP383-391 (SRYWAIRTR), and HIV gag 264-273 (KRWIILGLNK). Long-term non-progression during HIV infection has been associated with presentation by HLA-B*2705, and T cell recognition, of the highly immunodominant KRWIILGLNK peptide. The tight hydrogen-bonding network observed between the HLA-B*2705 B-pocket and the peptide P2 arginine guanadinium anchor explains why mutation of this residue during HIV infection results in loss of peptide binding, immune escape and progression to AIDS. Prominent, solvent-exposed structures within these peptides may participate in generating T cell responses to these immunodominant epitopes. In the HLA-B*2705 complex with flu NP383-391, the amino acid side chains of residues 4, 7 and 8 are solvent-exposed whilst in the HIV decamer, the main-chain bulges into the solvent around P7. Thus, HLA-B*2705 presents viral peptides in a range of conformations. Tetrameric complexes of HLA-B*2705 with the HIV and flu but not EBV peptides bound strongly to the killer-Ig-like receptor (KIR)3DL1. Substitution of EBV P8 glutamate to threonine allowed recognition by KIR3DL1. In the HLA-B*2705-EBV structure the P8 glutamate side chain is solvent-exposed and may inhibit KIR3DL1 binding through electrostatic forces.
Insights
We determined the crystal structures of HLA-B*2705 complexes with viral peptides from EBV, influenza, and HIV. These structures reveal how HLA-B*2705 presents peptides, influencing T cell responses and immune evasion in HIV infection.
Area of Science:
- Immunology
- Structural Biology
- Virology
Background:
- HLA-B*2705 is crucial for presenting viral peptides to T cells, impacting HIV progression.
- Understanding HLA-B*2705-peptide interactions is key to T cell recognition and immune responses.
Purpose of the Study:
- To elucidate the structural basis of HLA-B*2705 presenting immunodominant viral peptides.
- To investigate the role of peptide conformation and specific residues in T cell and KIR3DL1 recognition.
Main Methods:
- X-ray crystallography to solve the structures of three HLA-B*2705-peptide complexes.
- Analysis of peptide binding and interactions within the HLA-B*2705 B-pocket.
- Assessment of tetrameric complex binding to the killer-Ig-like receptor (KIR)3DL1.
Main Results:
- Crystal structures of HLA-B*2705 with EBV, influenza, and HIV peptides were determined.
- A key arginine anchor in the HIV peptide explains immune escape upon mutation.
- HLA-B*2705 presents peptides in diverse conformations, with exposed residues influencing interactions.
- HIV and influenza peptide complexes bound KIR3DL1, unlike the EBV peptide complex, which could be altered by mutation.
Conclusions:
- HLA-B*2705 exhibits varied peptide presentation, influencing immune recognition.
- Structural insights explain HIV immune escape mechanisms related to peptide binding.
- Peptide features and HLA-B*2705 conformation dictate KIR3DL1 interactions, offering potential therapeutic targets.
Related Concept Videos
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...


